Scarica l'app Stockscreener
272.10
1.07%
-3.74
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$275.84
Aprire:
$269.45
Volume 24 ore:
2.60M
Relative Volume:
0.87
Capitalizzazione di mercato:
$156.43B
Reddito:
$34.13B
Utile/perdita netta:
$5.93B
Rapporto P/E:
24.83
EPS:
10.96
Flusso di cassa netto:
$10.92B
1 W Prestazione:
-3.83%
1M Prestazione:
-2.63%
6M Prestazione:
-16.10%
1 anno Prestazione:
-11.20%
Intervallo 1D:
$266.02
$274.78
Intervallo di 1 settimana:
$266.02
$291.61
Portata 52W:
$253.30
$346.85
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Confronta AMGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
272.23 | 156.43B | 34.13B | 5.93B | 10.92B | 10.96 |
|
LLY
Lilly Eli Co
|
752.45 | 681.85B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
155.50 | 370.90B | 89.33B | 21.81B | 18.57B | 8.99 |
|
ABBV
Abbvie Inc
|
185.30 | 345.13B | 57.37B | 4.20B | 17.83B | 2.35 |
|
NVO
Novo Nordisk Adr
|
64.99 | 294.98B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
NVS
Novartis Ag Adr
|
110.16 | 224.15B | 53.22B | 12.86B | 14.85B | 6.39 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-22 | Ripresa | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-10-17 | Iniziato | Bernstein | Outperform |
| 2024-10-14 | Downgrade | Truist | Buy → Hold |
| 2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Ripresa | Raymond James | Mkt Perform |
| 2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-02 | Aggiornamento | Truist | Hold → Buy |
| 2023-10-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Ripresa | BofA Securities | Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-04-24 | Reiterato | Oppenheimer | Outperform |
| 2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Reiterato | Truist | Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Underperform |
| 2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-02-09 | Reiterato | Barclays | Equal Weight |
| 2022-02-09 | Reiterato | Jefferies | Buy |
| 2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Reiterato | Oppenheimer | Outperform |
| 2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
| 2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Iniziato | Daiwa Securities | Buy |
| 2020-10-28 | Iniziato | UBS | Neutral |
| 2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Aggiornamento | Truist | Hold → Buy |
| 2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Downgrade | Truist | Buy → Hold |
| 2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Ripresa | Guggenheim | Neutral |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-17 | Ripresa | Morgan Stanley | Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
| 2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
Amgen CEO Robert A. Bradway to Receive Honorary Degree from KGI - Eagle-Tribune
Amgen CEO Robert A. Bradway to Receive Honorary Degree from KGI - GlobeNewswire Inc.
38,090 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Cutter Capital Management LP - MarketBeat
Capital Advantage Inc. Purchases New Shares in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Erste Group cuts Amgen stock rating to Hold from Buy - Investing.com
MHRA approves Amgen’s Tepezza for TED - The Pharma Letter
Amgen (AMGN) Downgraded by Analyst Due to Future Growth Concerns | AMGN Stock News - GuruFocus
MHRA approves Amgen’s Tepezza for NED - The Pharma Letter
AQR Capital Management LLC Trims Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Alteri Wealth LLC Purchases Shares of 11,903 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Caisse DE Depot ET Placement DU Quebec Sells 144,409 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
UK's MHRA Approves Amgen's Thyroid Eye Disease Treatment - marketscreener.com
Ameriprise Financial Inc. Boosts Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bridgefront Capital LLC Acquires 3,103 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
BLI Banque de Luxembourg Investments Invests $2.20 Million in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
1,330 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Alethea Capital Management LLC - MarketBeat
Mercer Global Advisors Inc. ADV Acquires New Shares in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Aristotle Capital Management LLC Sells 16,789 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen's (AMGN) Tepezza Gains U.K. Approval for Thyroid Eye Disease - GuruFocus
Amgen Inc. (AMGN): A Bull Case Theory - Insider Monkey
Is Amgen Inc. (AMGN) the Best Dow Stock? - Yahoo Finance
Amgen wins U.K. nod for Tepezza in TED (AMGN:NASDAQ) - Seeking Alpha
What the Options Market Tells Us About Amgen - Nasdaq
Amgen (AMGN) Gains UK Approval for Tepezza in Thyroid Eye Disease Treatment | AMGN Stock News - GuruFocus
Amgen says MHRA granted marketing authorization to Tepezza for TED - TipRanks
Amgen’s TEPEZZA®▼ (teprotumumab) Granted Marketing Authorisation as the First Targeted Treatment Specifically for Adults With Moderate-to-severe Thyroid Eye Disease (TED) in the United Kingdom - Business Wire
The Best and Worst Dow Stocks - Insider Monkey
Forecasting The Future: 7 Analyst Projections For Amgen - Benzinga
Here's Why Amgen (AMGN) is a Strong Growth Stock - Yahoo Finance
Analyst Update: Amgen (AMGN) Price Target Raised to $280 by Mizuho | AMGN Stock News - GuruFocus
Amgen (AMGN) Price Target Increased by Mizuho Following Q1 Updat - GuruFocus
Captrust Financial Advisors Buys 10,753 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Brown Advisory Inc. Has $94.24 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Benjamin Edwards Inc. Raises Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Axa S.A. Sells 89,434 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bayesian Capital Management LP Purchases Shares of 43,000 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by BNP Paribas - MarketBeat
Mizuho Raises Price Target on Amgen to $280 From $235 - marketscreener.com
Bellevue Group AG Grows Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen ploughing $900m into Ohio production site - BioProcess International
Here's Why Amgen (AMGN) is a Strong Value Stock - Yahoo
Amgen Biosimilars Continue Surge Ahead Of Imminent Denosumab Competition - insights.citeline.com
Amgen: Waiting Patiently For A Real Catalyst - Seeking Alpha
Baird Financial Group Inc. Lowers Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Banque Transatlantique SA Purchases New Shares in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Aptus Capital Advisors LLC Acquires 16,380 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
FY2025 EPS Estimates for Amgen Boosted by Cantor Fitzgerald - MarketBeat
Navigoe LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Meiji Yasuda Life Insurance Co Sells 3,837 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Ancora Advisors LLC Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
PDT Partners LLC Increases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.99%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):